SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-011824
Filing Date
2018-05-08
Accepted
2018-05-08 16:16:11
Documents
44
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 KURA-10Q-20180331 kura-10q_20180331.htm 10-Q 1393834
2 EX-10.1 kura-ex101_8.htm EX-10.1 14281
3 EX-31.1 kura-ex311_7.htm EX-31.1 17186
4 EX-31.2 kura-ex312_9.htm EX-31.2 16952
5 EX-32.1 kura-ex321_6.htm EX-32.1 9615
  Complete submission text file 0001564590-18-011824.txt   4487660

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kura-20180331.xml EX-101.INS 1056683
7 XBRL TAXONOMY EXTENSION SCHEMA kura-20180331.xsd EX-101.SCH 29609
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kura-20180331_cal.xml EX-101.CAL 33933
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kura-20180331_def.xml EX-101.DEF 69458
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20180331_lab.xml EX-101.LAB 201208
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20180331_pre.xml EX-101.PRE 146233
Mailing Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121
Business Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37620 | Film No.: 18814758
SIC: 2834 Pharmaceutical Preparations